Adjustment of therapy in rheumatoid arthritis on the basis of achievement of stable low disease activity with adalimumab plus methotrexate or methotrexate alone: the randomised controlled OPTIMA trial
Josef S Smolen,Paul Emery,Roy Fleischmann,Ronald F van Vollenhoven,Karel Pavelka,Patrick Durez,Benoît Guérette,Hartmut Kupper,Laura Redden,Vipin Arora,Arthur Kavanaugh
25–31 January 2014
Copyright © 2014, Elsevier
Welcome to RightsLink
Elsevier has partnered with Copyright Clearance Center's RightsLink service to offer a variety of options for reusing Elsevier content. Select the "I would like to ..." drop-down menu to view the many reuse options available to you.
I would like to...
To request permission for a type of use not listed, please contact Elsevier Global Rights Department.Are you the author of this Elsevier journal article?
Clearance Center, Inc. All Rights Reserved.
Comments? We would like to hear from you. E-mail us at